Citizens JMP analyst Constantine Davides upgraded Cross Country Healthcare (CCRN) to Outperform from Market Perform with an $11 price target
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCRN:
- Cross Country Healthcare: Navigating Post-Acquisition Challenges with Financial Stability and Growth Potential
- Cross Country Healthcare Ends Merger with Aya Holdings
- Cross Country Healthcare, Aya Healthcare merger agreement terminated
- Cross Country Healthcare Reports Q3 2025 Financial Results
- Cross Country Healthcare’s Financial Stability at Risk: Unforeseen Challenges Ahead